- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Nichi-iko Pharmaceutical Co Ltd
+ Add to Watchlist4541:JP
2,494 JPY 34 1.38%As of 02:00:00 ET on 05/17/2013.
Snapshot for Nichi-iko Pharmaceutical Co Ltd (4541)
| Open: | 2,423 | Day's Range: | 2,422 - 2,500 | Volume: | 231,700 |
|---|---|---|---|---|---|
| Previous Close: | 2,460 | 52wk Range: | 1,404 - 2,550 | 1-Yr Rtn: | +66.19% |
Key Statistics for 4541
| Current P/E Ratio (ttm) | 19.5198 |
|---|---|
| Estimated P/E(03/2014) | 17.5232 |
| Relative P/E vs. TPX | 0.8066 |
| Earnings Per Share (JPY) (ttm) | 127.7680 |
| Est. EPS (JPY) (03/2014) | 142.3260 |
| Est. PEG Ratio | 0.8113 |
| Market Cap (M JPY) | 101,579.16 |
| Shares Outstanding (M) | 40.73 |
| 30 Day Average Volume | 247,577 |
| Price/Book (mrq) | 2.0363 |
| Price/Sale (ttm) | 1.0671 |
| Dividend Indicated Gross Yield | 1.28% |
| Cash Dividend (JPY) | 16.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 13.49% |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4541
Company Profile & Key Executives for 4541
Nichi-iko Pharmaceutical Co., Ltd. manufactures and sells prescription drugs. The Company developed measuring application for patients to prevent from any respiratory fits such as asthma. Nichiiko Pharmaceutical also offers information on medical drugs and supplies through internet.
| Yuichi TamuraPresident | Toshinori KongohjiSenior Managing Exec Officer |
| Shuko UrayamaSenior Managing Exec Officer | Kenji AkaneSenior Managing Exec Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4541 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page